United States · Bill · HR
H.R. 4242 (106th)
Orphan Drug Innovation Act
Introduced
11 April 2000
Last action
—
Status
Referred to the Subcommittee on Health and Environment.
Sponsors
—
Subjects
Discovery layer
Source updated
3 June 2026
Summary
Orphan Drug Innovation Act - Amends the Federal Food, Drug and Cosmetic Act, with respect to orphan drugs, to provide for the waiver of the seven-year prohibition against approval for a drug which is clinically superior to an approved drug.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 11 April 2000
Introduced in House (PDF)
Introduced in House · EN · 11 April 2000
Introduced in House
summary · EN · 11 April 2000
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/106th-congress/house-bill/4242
- Open data entity: https://api.congress.gov/v3/bill/106/hr/4242